Company Filing History:
2 out of 4,455 
2 out of 15,475 
Years Active: 2022-2025
Title: The Innovative Contributions of Charles Ray Holst
Introduction
Charles Ray Holst is a notable inventor based in San Jose, CA (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, Holst's work focuses on the development of antibodies that target specific integrins involved in cancer progression.
Latest Patents
Holst's latest patents include a "Method of treating cancer using anti-AV8 antibodies." This invention provides antibodies and antigen-binding fragments that specifically bind to αvβ8 integrin. The invention encompasses various uses and associated methods for utilizing these antibodies. Another significant patent is "Anti-AVB8 antibodies and compositions and uses thereof," which also provides antibodies and antigen-binding fragments that specifically bind to αvβ8 integrin, along with their uses and methods.
Career Highlights
Throughout his career, Holst has worked with prominent organizations such as Pfizer Corporation and the University of California. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of Holst's notable coworkers include Kyle Steven Niessen and Dharmaraj Samuel. Their collaborative efforts have further enhanced the impact of his research in the field.
Conclusion
Charles Ray Holst's innovative work in developing cancer treatment methods through targeted antibodies showcases his dedication to advancing medical science. His contributions are significant in the ongoing fight against cancer, and his patents reflect a commitment to improving patient outcomes.